Showing results (1-10 of 5,744) with videos related to
Sort By:
Pageof 575
Cancer Immunology, Immunotherapy : CII|January 1, 1984
Virus-augmented delayed hypersensitivity skin tests in gynecological malignanciesR S Freedman, J M Bowen, E N Atkinson, et al.European Journal of Cancer & Clinical Oncology|November 1, 1989
Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetateJ L Tatman, R S Freedman, W Scott, et al.Cancer|November 1, 1991
Sequentially administered ethinyl estradiol and medroxyprogesterone acetate in the treatment of refractory epithelial ovarian carcinoma in patients with positive estrogen receptorsG L Fromm, R S Freedman, H A Fritsche, et al.American Journal of Clinical Oncology|June 1, 1989
Randomized comparison of viral oncolysate plus radiation and radiation alone in uterine cervix carcinomaR S Freedman, J M Bowen, E N Atkinson, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extractE Lotzová, C A Savary, R S Freedman, et al.Natural Immunity and Cell Growth Regulation|January 1, 1983
Augmentation of in vitro lymphocyte blastogenesis and cytotoxicity responses by tumor cells modified with dodecanoyl cytochrome CJ W Davis, R S Freedman, N Atkinson, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.Journal of Immunological Methods|January 3, 1994
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapyR S Freedman, B Tomasovic, S Templin, et al.Anticancer Research|January 1, 1989
Increased ovarian tumor cell surface reacting antibodies in patients with ovarian adenocarcinoma after viral oncolysate treatmentC G Ioannides, C D Platsoucas, J M Bowen, et al.Lymphokine Research|January 1, 1989
Lymphokine activity in malignant effusions after intracavitary viral oncolysateR S Freedman, N M Kouttab, J M Bowen, et al.Pageof 575